These contraindications are not suggestions
You need to know about rare but serious adverse effects and how to recognize them
Methods We searched PubMed, Embase, Cochrane and ClinicalTrials.gov up until 27 October 2021 for randomised controlled trials with a duration of at least 12 weeks that compared once-weekly tirzepatide 5, 10 or 15 mg with placebo or other glucose-lowering drugs in adults with type 2 diabetes irrespective of their background glucose-lowering treatment
US$ 25.31 You save US$ 1.33
References Maier, C., Hartung, N., de Wiljes, J., Kloft, C., & Huisinga, W